GlassScriptPhysician profile
Kari Colen
NPI 1093972598
$4,980.74
in general payments reported to CMS, 2019-2025
12 companies · $244 in 2025
The $244 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,317 · 2020: $32.98 · 2021: $261 · 2022: $360 · 2023: $295 · 2024: $2,471 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,815 · Food and Beverage: $1,195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,815.45 |
| Food and Beverage | $1,194.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,531.15 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Alloderm |
| Kci USA, INC. | $958.76 | 2019-2021 | |
| Sientra, INC. | $333.05 | 2019-2021 | |
| Allergan, INC. | $229.67 | 2019-2022 | |
| Mentor Worldwide LLC | $211.69 | 2022-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Davol INC. | $178.05 | 2019-2025 | Channel Drain |
| Sanara Medtech INC. | $143.12 | 2024 | Celleraterx |
| Stryker Corporation | $100.00 | 2019 | |
| Seapearl East, INC | $100.00 | 2024 | |
| Checkpoint Surgical, INC | $96.04 | 2022 | |
| Axogen | $70.87 | 2023-2024 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Tela Bio, INC. | $28.34 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kari Colen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.